文献
J-GLOBAL ID:201202286527085762
整理番号:12A1699314
ヒト上皮成長因子受容体2過剰発現による転移性骨肉腫治療において細胞傷害性化学療法と併用するトラスツズマブの第II相試験: 小児腫瘍グループからの報告
Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children’s Oncology Group
著者 (17件):
EBB David
(Massachusetts General Hospital)
,
MEYERS Paul
(Memorial Sloan-Kettering Cancer Center)
,
GRIER Holcombe
(Massachusetts General Hospital)
,
BERNSTEIN Mark
(IWK Health Centre, Nova Scotia, CAN)
,
GORLICK Richard
(Montefiore Medical Center, NY)
,
LIPSHULTZ Steven E.
(Univ. of Miami Miller School of Medicine, Miami)
,
KRAILO Mark
(Univ. of Southern California, Los Angeles)
,
DEVIDAS Meenakshi
(Children’s Oncology Group, Gainesville)
,
BARKAUSKAS Donald A.
(Univ. of Southern California, Los Angeles)
,
SIEGAL Gene P.
(Univ. of Alabama, AL)
,
FERGUSON William Shay
(Cardinal Glennon Children’s Hospital, MO)
,
LETSON George Douglas
(H. Lee Moffitt Cancer Center, FL)
,
MARCUS Karen
(Massachusetts General Hospital)
,
GOORIN Allen
(Dana-Farber Cancer Inst., MA)
,
BEARDSLEY Peter
(Yale Univ., CT)
,
MARINA Neyssa
(Lucile Packard Children’s Hospital)
,
MARINA Neyssa
(Stanford Univ., CA)
資料名:
Journal of Clinical Oncology
(Journal of Clinical Oncology)
巻:
30
号:
20
ページ:
2545-2551
発行年:
2012年07月10日
JST資料番号:
E0307D
ISSN:
0732-183X
資料種別:
逐次刊行物 (A)
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)